NEPHROCARE GMP TODAY
Nephrocare Health IPO Day 3: GMP slips to 2% and subscription remains subdued — Should you apply?Nephrocare Health IPO: The stock’s grey-market premium has slipped to 1.7% from 4.35%, indicating softer sentiment and a likely listing ran...
Nephrocare Health IPO Day 2: GMP improves but subscription demand remains weak. Should you apply?Nephrocare Health Services’ Rs 871-crore IPO has seen a muted initial response despite an improving grey market premium. Strong financial g...
Nephrocare Health IPO Day 1: Issue subscribed 7%; no GMP. Should investors apply?Nephrocare Health IPO consists of a ₹353-crore fresh issue and a ₹518-crore offer for sale. Of the fresh issue funds, Nephrocare Health Ser...
Nephrocare Health IPO: Check GMP, review, subscription and other detailsNephrocare Health Services, India's largest dialysis provider, launched its Rs 871 crore IPO on Wednesday, offering a stake in its rapidly ...
Load More